Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patricia Morateck

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Blood|July 13, 2006
Assay of the von Willebrand factor (VWF) propeptide to identify patients with type 1 von Willebrand disease with decreased VWF survivalSandra L Haberichter, Michael Balistreri, Pamela Christopherson, et al.
Blood Vessels, Thrombosis & Hemostasis|September 8, 2025
iMer, a naturally occurring MERTK splice variant, binds to GAS6 to decrease platelet activation and thrombus formationStephanie Springborn, Samantha Judd, Patricia Morateck, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Blood|July 13, 2006
Assay of the von Willebrand factor (VWF) propeptide to identify patients with type 1 von Willebrand disease with decreased VWF survivalSandra L Haberichter, Michael Balistreri, Pamela Christopherson, et al.
Blood Vessels, Thrombosis & Hemostasis|September 8, 2025
iMer, a naturally occurring MERTK splice variant, binds to GAS6 to decrease platelet activation and thrombus formationStephanie Springborn, Samantha Judd, Patricia Morateck, et al.
Pageof 1